213 related articles for article (PubMed ID: 34144008)
1. MALAT1: A Promising Therapeutic Target for the Treatment of Metastatic Colorectal Cancer.
Uthman YA; Ibrahim KG; Abubakar B; Bello MB; Malami I; Imam MU; Qusty N; Cruz-Martins N; Batiha GE; Abubakar MB
Biochem Pharmacol; 2021 Aug; 190():114657. PubMed ID: 34144008
[TBL] [Abstract][Full Text] [Related]
2. Chronic oxymatrine treatment induces resistance and epithelial‑mesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells.
Xiong Y; Wang J; Zhu H; Liu L; Jiang Y
Oncol Rep; 2018 Mar; 39(3):967-976. PubMed ID: 29328404
[TBL] [Abstract][Full Text] [Related]
3. Association of MALAT1 and PVT1 Variants, Expression Profiles and Target miRNA-101 and miRNA-186 with Colorectal Cancer: Correlation with Epithelial-Mesenchymal Transition.
Radwan AF; Shaker OG; El-Boghdady NA; Senousy MA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200314
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/β-catenin signal pathway.
Ji Q; Liu X; Fu X; Zhang L; Sui H; Zhou L; Sun J; Cai J; Qin J; Ren J; Li Q
PLoS One; 2013; 8(11):e78700. PubMed ID: 24244343
[TBL] [Abstract][Full Text] [Related]
5. Thapsigargin promotes colorectal cancer cell migration through upregulation of lncRNA MALAT1.
Jiang X; Li D; Wang G; Liu J; Su X; Yu W; Wang Y; Zhai C; Liu Y; Zhao Z
Oncol Rep; 2020 Apr; 43(4):1245-1255. PubMed ID: 32323831
[TBL] [Abstract][Full Text] [Related]
6. MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2.
Li P; Zhang X; Wang H; Wang L; Liu T; Du L; Yang Y; Wang C
Mol Cancer Ther; 2017 Apr; 16(4):739-751. PubMed ID: 28069878
[TBL] [Abstract][Full Text] [Related]
7. Exosomal MALAT1 sponges miR-26a/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K/Akt pathway.
Xu J; Xiao Y; Liu B; Pan S; Liu Q; Shan Y; Li S; Qi Y; Huang Y; Jia L
J Exp Clin Cancer Res; 2020 Mar; 39(1):54. PubMed ID: 32209115
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of MALAT1 reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer.
Tang D; Yang Z; Long F; Luo L; Yang B; Zhu R; Sang X; Cao G
Cell Signal; 2019 May; 57():21-28. PubMed ID: 30716387
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MALAT1 regulates trophoblast cells migration and invasion via miR-206/IGF-1 axis.
Wu HY; Wang XH; Liu K; Zhang JL
Cell Cycle; 2020 Jan; 19(1):39-52. PubMed ID: 31774373
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex.
Ji Q; Zhang L; Liu X; Zhou L; Wang W; Han Z; Sui H; Tang Y; Wang Y; Liu N; Ren J; Hou F; Li Q
Br J Cancer; 2014 Aug; 111(4):736-48. PubMed ID: 25025966
[TBL] [Abstract][Full Text] [Related]
13. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
Shi B; Wang Y; Yin F
Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
[TBL] [Abstract][Full Text] [Related]
14. Exploring the Key Signaling Pathways and ncRNAs in Colorectal Cancer.
Lee YJ; Kim WR; Park EG; Lee DH; Kim JM; Shin HJ; Jeong HS; Roh HY; Kim HS
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674135
[TBL] [Abstract][Full Text] [Related]
15. LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway.
Jin Y; Feng SJ; Qiu S; Shao N; Zheng JH
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3176-3184. PubMed ID: 28770968
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging.
Guo J; Ding Y; Yang H; Guo H; Zhou X; Chen X
Exp Mol Pathol; 2020 Aug; 115():104448. PubMed ID: 32380053
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer.
Xu S; Sui S; Zhang J; Bai N; Shi Q; Zhang G; Gao S; You Z; Zhan C; Liu F; Pang D
Int J Clin Exp Pathol; 2015; 8(5):4881-91. PubMed ID: 26191181
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Epigenetic Non-Coding RNA MALAT1/Wnt Signaling Axis as a Therapeutic Approach to Suppress Stemness and Metastasis in Hepatocellular Carcinoma.
Chang HL; Bamodu OA; Ong JR; Lee WH; Yeh CT; Tsai JT
Cells; 2020 Apr; 9(4):. PubMed ID: 32326045
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of long non-coding RNA-metastasis associated lung adenocarcinoma transcript 1 induced invasion and metastasis of esophageal cancer cell EC-109].
Zhang QQ; Cui YH; Wang Y; Kou WZ; Cao F; Cao XJ; Miao ZH; Kang XH
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):405-411. PubMed ID: 28635228
[No Abstract] [Full Text] [Related]
20. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1/microRNA-202-3p/periostin axis modulates invasion and epithelial-mesenchymal transition in human cervical cancer.
Han X; Wang Q; Wang Y; Hu B; Dong X; Zhang H; Wang W
J Cell Physiol; 2019 Aug; 234(8):14170-14180. PubMed ID: 30633360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
